• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非最佳血脂水平对未服用他汀类药物的年轻成年人冠状动脉钙化进展的影响:韩国国际协力团(KOICA)登记研究结果

The effect of non-optimal lipids on the progression of coronary artery calcification in statin-naïve young adults: results from KOICA registry.

作者信息

Lee Heesun, Ahn Hyo-Jeong, Park Hyo Eun, Han Donghee, Chang Hyuk-Jae, Chun Eun Ju, Han Hae-Won, Sung Jidong, Jung Hae Ok, Choi Su-Yeon

机构信息

Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.

Division of Cardiology, Healthcare System Gangnam Center, Seoul National University Hospital, Seoul, Republic of Korea.

出版信息

Front Cardiovasc Med. 2023 Jul 17;10:1173289. doi: 10.3389/fcvm.2023.1173289. eCollection 2023.

DOI:10.3389/fcvm.2023.1173289
PMID:37534276
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10392939/
Abstract

BACKGROUND

Despite the importance of attaining optimal lipid levels from a young age to secure long-term cardiovascular health, the detailed impact of non-optimal lipid levels in young adults on coronary artery calcification (CAC) is not fully explored. We sought to investigate the risk of CAC progression as per lipid profiles and to demonstrate lipid optimality in young adults.

METHODS

From the KOrea Initiative on Coronary Artery calcification (KOICA) registry that was established in six large volume healthcare centers in Korea, 2,940 statin-naïve participants aged 20-45 years who underwent serial coronary calcium scans for routine health check-ups between 2002 and 2017 were included. The study outcome was CAC progression, which was assessed by the square root method. The risk of CAC progression was analyzed according to the lipid optimality and each lipid parameter.

RESULTS

In this retrospective cohort (mean age, 41.3 years; men 82.4%), 477 participants (16.2%) had an optimal lipid profile, defined as triglycerides <150 mg/dl, LDL cholesterol <100 mg/dl, and HDL cholesterol >60 mg/dl. During follow-up (median, 39.7 months), CAC progression was observed in 434 participants (14.8%), and more frequent in the non-optimal lipid group (16.5% vs. 5.7%; < 0.001). Non-optimal lipids independently increased the risk of CAC progression [adjusted hazard ratio (aHR), 1.97; = 0.025], in a dose-dependent manner. Even in relatively low-risk participants with an initial calcium score of zero (aHR, 2.13; = 0.014), in their 20 s or 30 s (aHR 2.15; = 0.041), and without other risk factors (aHR 1.45; = 0.038), similar results were demonstrable. High triglycerides had the greatest impact on CAC progression in this young adult population.

CONCLUSION

Non-optimal lipid levels were significantly associated with the risk of CAC progression in young adults, even at low-risk. Screening and intervention for non-optimal lipid levels, particularly triglycerides, from an early age might be of clinical value.

摘要

背景

尽管从年轻时就达到最佳血脂水平对于确保长期心血管健康至关重要,但年轻成年人血脂水平不理想对冠状动脉钙化(CAC)的具体影响尚未得到充分研究。我们试图根据血脂谱调查CAC进展的风险,并证明年轻成年人的血脂最佳状态。

方法

从韩国在六个大型医疗中心建立的冠状动脉钙化韩国倡议(KOICA)登记处,纳入了2940名年龄在20-45岁之间、在2002年至2017年期间接受系列冠状动脉钙扫描进行常规健康检查的未服用他汀类药物的参与者。研究结果是CAC进展,通过平方根法进行评估。根据血脂最佳状态和每个血脂参数分析CAC进展的风险。

结果

在这个回顾性队列中(平均年龄41.3岁;男性占82.4%),477名参与者(16.2%)具有最佳血脂谱,定义为甘油三酯<150mg/dl、低密度脂蛋白胆固醇<100mg/dl和高密度脂蛋白胆固醇>60mg/dl。在随访期间(中位数为39.7个月),434名参与者(14.8%)出现了CAC进展,在血脂不理想组中更常见(16.5%对5.7%;P<0.001)。不理想的血脂独立增加了CAC进展的风险[调整后的危险比(aHR),1.97;P=0.025],呈剂量依赖性。即使在初始钙评分为零的相对低风险参与者中(aHR,2.13;P=0.014)、20多岁或30多岁的参与者中(aHR 2.15;P=0.041)以及没有其他风险因素的参与者中(aHR 1.45;P=0.038),也得到了类似的结果。在这个年轻成年人群体中,高甘油三酯对CAC进展的影响最大。

结论

即使在低风险情况下,不理想的血脂水平也与年轻成年人CAC进展的风险显著相关。从年轻时就对不理想的血脂水平,特别是甘油三酯进行筛查和干预可能具有临床价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d16a/10392939/97c7d8fc579e/fcvm-10-1173289-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d16a/10392939/35b231979ba6/fcvm-10-1173289-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d16a/10392939/9b226d62563b/fcvm-10-1173289-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d16a/10392939/5f97d7f48edd/fcvm-10-1173289-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d16a/10392939/97c7d8fc579e/fcvm-10-1173289-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d16a/10392939/35b231979ba6/fcvm-10-1173289-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d16a/10392939/9b226d62563b/fcvm-10-1173289-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d16a/10392939/5f97d7f48edd/fcvm-10-1173289-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d16a/10392939/97c7d8fc579e/fcvm-10-1173289-g004.jpg

相似文献

1
The effect of non-optimal lipids on the progression of coronary artery calcification in statin-naïve young adults: results from KOICA registry.非最佳血脂水平对未服用他汀类药物的年轻成年人冠状动脉钙化进展的影响:韩国国际协力团(KOICA)登记研究结果
Front Cardiovasc Med. 2023 Jul 17;10:1173289. doi: 10.3389/fcvm.2023.1173289. eCollection 2023.
2
Changes in metabolic syndrome burden and risk of coronary artery calcification progression in statin-naïve young adults.他汀类药物初治的年轻成年人代谢综合征负担变化与冠状动脉钙化进展的风险
Atherosclerosis. 2022 Nov;360:27-33. doi: 10.1016/j.atherosclerosis.2022.09.011. Epub 2022 Oct 7.
3
Variability in Lipid Profiles During Young Adulthood and the Risk of Coronary Artery Calcium Incidence in Midlife: Insights From the CARDIA Study.青年期血脂谱的变异性与中年冠心病钙沉积风险的关系:来自 CARDIA 研究的见解。
Circ Cardiovasc Imaging. 2024 Sep;17(9):e016842. doi: 10.1161/CIRCIMAGING.123.016842. Epub 2024 Sep 13.
4
Remnant Cholesterol and the Risk of Coronary Artery Calcium Progression: Insights From the CARDIA and MESA Study.残胆固醇与冠状动脉钙进展风险:来自 CARDIA 和 MESA 研究的新见解。
Circ Cardiovasc Imaging. 2022 Jul;15(7):e014116. doi: 10.1161/CIRCIMAGING.122.014116. Epub 2022 Jul 8.
5
Increased risk of coronary artery calcification progression in subjects with high baseline Lp(a) levels: The Kangbuk Samsung Health Study.高基线脂蛋白(a)水平受试者冠状动脉钙化进展风险增加:江北三星健康研究
Int J Cardiol. 2016 Nov 1;222:233-237. doi: 10.1016/j.ijcard.2016.07.219. Epub 2016 Jul 31.
6
Relation of coronary calcium progression and control of lipids according to National Cholesterol Education Program guidelines.根据美国国家胆固醇教育计划指南,冠状动脉钙化进展与血脂控制的关系。
Am J Cardiol. 2004 Aug 15;94(4):431-6. doi: 10.1016/j.amjcard.2004.05.003.
7
Sex differences in coronary artery calcium progression: The Korea Initiatives on Coronary Artery Calcification (KOICA) registry.冠状动脉钙进展的性别差异:韩国冠状动脉钙化倡议 (KOICA) 登记研究。
PLoS One. 2021 Apr 8;16(4):e0248884. doi: 10.1371/journal.pone.0248884. eCollection 2021.
8
Evaluation of Coronary Artery Calcium Progression in Asymptomatic Individuals with an Initial Score of Zero.初始分数为零的无症状个体的冠状动脉钙化进展评估。
Korean Circ J. 2019 May;49(5):448-457. doi: 10.4070/kcj.2018.0318. Epub 2019 Feb 14.
9
Association between atherogenic index of plasma and coronary artery calcification progression in Korean adults.韩国成年人血浆致动脉粥样硬化指数与冠状动脉钙化进展之间的关联。
Lipids Health Dis. 2020 Jul 2;19(1):157. doi: 10.1186/s12944-020-01317-4.
10
Evaluation of the impact of glycemic status on the progression of coronary artery calcification in asymptomatic individuals.评价血糖状态对无症状个体冠状动脉钙化进展的影响。
Cardiovasc Diabetol. 2018 Jan 4;17(1):4. doi: 10.1186/s12933-017-0653-0.

本文引用的文献

1
Predictors of Coronary Artery Calcium and Long-Term Risks of Death, Myocardial Infarction, and Stroke in Young Adults.预测青年人群冠状动脉钙化和长期死亡、心肌梗死及卒中等风险因素。
J Am Heart Assoc. 2021 Nov 16;10(22):e022513. doi: 10.1161/JAHA.121.022513. Epub 2021 Nov 6.
2
Modeling the Recommended Age for Initiating Coronary Artery Calcium Testing Among At-Risk Young Adults.建模推荐的起始年龄进行冠状动脉钙测试的高危年轻成年人。
J Am Coll Cardiol. 2021 Oct 19;78(16):1573-1583. doi: 10.1016/j.jacc.2021.08.019.
3
Triglyceride Levels and Residual Risk of Atherosclerotic Cardiovascular Disease Events and Death in Adults Receiving Statin Therapy for Primary or Secondary Prevention: Insights From the KP REACH Study.
接受他汀类药物一级或二级预防治疗的成年人的甘油三酯水平与动脉粥样硬化性心血管疾病事件和死亡的残余风险:来自 KP REACH 研究的见解。
J Am Heart Assoc. 2021 Oct 19;10(20):e020377. doi: 10.1161/JAHA.120.020377. Epub 2021 Oct 8.
4
2018 Guidelines for the Management of Dyslipidemia in Korea.《2018年韩国血脂异常管理指南》
J Lipid Atheroscler. 2019 Sep;8(2):78-131. doi: 10.12997/jla.2019.8.2.78. Epub 2019 Aug 7.
5
Predictors of coronary artery calcium among 20-30-year-olds: The Coronary Artery Calcium Consortium.20至30岁人群冠状动脉钙化的预测因素:冠状动脉钙化联盟
Atherosclerosis. 2020 May;301:65-68. doi: 10.1016/j.atherosclerosis.2020.04.006. Epub 2020 Apr 9.
6
Triglyceride glucose index is an independent predictor for the progression of coronary artery calcification in the absence of heavy coronary artery calcification at baseline.甘油三酯葡萄糖指数是基线时无重度冠状动脉钙化的情况下冠状动脉钙化进展的独立预测因子。
Cardiovasc Diabetol. 2020 Mar 16;19(1):34. doi: 10.1186/s12933-020-01008-5.
7
Association of four lipid components with mortality, myocardial infarction, and stroke in statin-naïve young adults: A nationwide cohort study.未服用他汀类药物的年轻成年人中四种脂质成分与死亡率、心肌梗死和中风的关联:一项全国性队列研究。
Eur J Prev Cardiol. 2020 May;27(8):870-881. doi: 10.1177/2047487319898571. Epub 2020 Feb 3.
8
2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk.2019年欧洲心脏病学会/欧洲动脉粥样硬化学会血脂异常管理指南:通过血脂修饰降低心血管风险
Atherosclerosis. 2019 Nov;290:140-205. doi: 10.1016/j.atherosclerosis.2019.08.014. Epub 2019 Aug 31.
9
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.2019年欧洲心脏病学会/欧洲动脉粥样硬化学会血脂异常管理指南:通过血脂修饰降低心血管风险
Eur Heart J. 2020 Jan 1;41(1):111-188. doi: 10.1093/eurheartj/ehz455.
10
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2018 年美国心脏病学会/美国心脏协会/美国心血管血管造影和介入学会/美国预防、物理治疗和康复医师学会/美国糖尿病协会/美国老年学会/美国药学会/美国医师协会/美国生理学会/北美介入放射学会/美国国家脂质协会/美国临床内分泌医师协会胆固醇管理指南:美国心脏病学会/美国心脏协会临床实践指南工作组的报告。
Circulation. 2019 Jun 18;139(25):e1082-e1143. doi: 10.1161/CIR.0000000000000625. Epub 2018 Nov 10.